CAS 1883747-71-4

Quabodepistat-d4 (OPC-167832-d4)

CAS: 1883747-71-4

Fórmula: C₂₁H₁₆D₄ClF₃N₂O₄

Peso molecular: 460.87

Ref: 4Z-Q-022002

Quabodepistat (OPC-167832)

CAS: 1883747-71-4

Fórmula: C₂₁H₂₀ClF₃N₂O₄

Peso molecular: 456.85

Ref: 4Z-Q-022001

Quabodepistat

Producto controlado

CAS: 1883747-71-4

Fórmula: C₂₁H₂₀ClF₃N₂O₄

Forma y color: Neat

Peso molecular: 456.85

Ref: TR-Q757740

OPC-167832

CAS: 1883747-71-4

OPC-167832 is a potent medicinal compound that has shown promising results in the treatment of cancer. It is an inhibitor of protein kinases, which are enzymes involved in cell cycle regulation and tumor growth. OPC-167832 induces apoptosis, or programmed cell death, in various cancer cell lines including Chinese hamster ovary cells and human tumor cells. This compound has been shown to have anticancer properties by inhibiting the growth of tumors and reducing their size. Additionally, OPC-167832 can be detected in urine samples, making it a useful tool for monitoring treatment response in cancer patients. Overall, this inhibitor shows great potential as a therapeutic agent for the treatment of various types of cancer.

Fórmula: C₂₁H₂₀ClF₃N₂O₄

Pureza: Min. 95%

Peso molecular: 456.8 g/mol

Ref: 3D-IAD74771

OPC-167832

CAS: 1883747-71-4

OPC-167832: oral dprE1 inhibitor, IC50 0.258 μM, anti-tuberculosis, for Mycobacterium tuberculosis research.

Fórmula: C₂₁H₂₀ClF₃N₂O₄

Forma y color: Solid

Peso molecular: 456.84

Ref: TM-T37880